Call Options Transactions Made in Q3 2024 in Pyxis Oncology, Inc. (PYXS)
This table provides information about the institutional ownership of Pyxis Oncology, Inc. (PYXS) during Q3 2024. The information is specifically focused on institutions that hold call options of Pyxis Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
355K+ 9900.0% |
$1M - $1.4M
|
359K
$606K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
47.6KNew |
$135K - $188K
|
47.6K
$80.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
1.4K+ 6.25% |
$3.96K - $5.52K
|
23.8K
$40.2K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
600+ 6.67% |
$1.7K - $2.36K
|
9.6K
$16.2K
|